UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036819
Receipt number R000041740
Scientific Title Effects of guidance and the management of exercise to outpatients with hematological malignancies undergoing chemotherapy
Date of disclosure of the study information 2019/05/22
Last modified on 2019/11/21 09:18:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of guidance and the management of exercise to outpatients with hematological malignancies undergoing chemotherapy

Acronym

Effects of guidance and the management of exercise to patients with hematological malignancies undergoing chemotherapy

Scientific Title

Effects of guidance and the management of exercise to outpatients with hematological malignancies undergoing chemotherapy

Scientific Title:Acronym

Effects of guidance and the management of exercise to patients with hematological malignancies undergoing chemotherapy

Region

Japan


Condition

Condition

Hematological Malignancies

Classification by specialty

Hematology and clinical oncology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Inspecting of the effects of guidance and the management of exercise to outpatients with malignant lymphoma undergoing chemotherapy

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Activity

Key secondary outcomes

Physical function
Physical symptom
Motor self-efficacy
Quality of lufe


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Pseudo-randomization


Intervention

No. of arms

2

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Behavior,custom

Interventions/Control_1

guidance of home-exercise

Interventions/Control_2

management of home-exercise

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

outpatient who can exercise in home
outpatient who get permission of medical doctor
outpatient who agree the participation to this study after enough understanding

Key exclusion criteria

when the medical doctor do not agree
when physical status of the patient is bad
when the patient have severe heart disease
when the patient have severe ischemic disorder
when the patient can not communicate with researcher

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Jiro
Middle name
Last name Naknao

Organization

Nagasaki University

Division name

Institute of Biomedical Sciences (Health sciences)

Zip code

8528520

Address

1-7-1 Sakamoto, Nagasaki-shi, Nagasaki

TEL

+81958197919

Email

nakano-j@nagasaki-u.ac.jp


Public contact

Name of contact person

1st name Jiro
Middle name
Last name Naknao

Organization

Nagasaki University

Division name

Institute of Biomedical Sciences (Health sciences)

Zip code

8528520

Address

1-7-1 Sakamoto, Nagasaki-shi, Nagasaki

TEL

+81958197919

Homepage URL


Email

nakano-j@nagasaki-u.ac.jp


Sponsor or person

Institute

Nagasaki University

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

nakano-j@nagasaki-u.ac.jp

Address

1-7-1 Sakamoto, Nagasaki-shi, Nagasaki

Tel

+81958197919

Email

nakano-j@nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

長崎大学病院/Nagasaki University Hospital


Other administrative information

Date of disclosure of the study information

2019 Year 05 Month 22 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2019 Year 05 Month 22 Day

Date of IRB

2019 Year 05 Month 21 Day

Anticipated trial start date

2019 Year 05 Month 22 Day

Last follow-up date

2020 Year 04 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2019 Year 05 Month 22 Day

Last modified on

2019 Year 11 Month 21 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041740